Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma

Published:2004-06 Issue:6 Volume:63 Page:1061-1065
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Clark Peter E.,Hall M.Craig,Miller Antonius,Ridenhour Kevin P.,Stindt Diana,Lovato James F.,Patton Suzanne E.,Brinkley William,Das Sarab,Torti Frank M.

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. Jemal A, Tiwari RC, Murray T, et al:Cancer statistics, 2004. CA Cancer J Clin 54:8–29, 2004.

2. The natural history of metastatic renal cell carcinoma;Dekernion;J Urol,1978

3. Follow-up after partial or total nephrectomy for renal cell carcinoma;Montie;Urol Clin North Am,1994

4. Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer;Heinzer;World J Urol,2001

5. Cytokine therapy for metastatic renal cell carcinoma;Bukowski;Semin Urol Oncol,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview;Metabolites;2023-04-11

2. Immunomodulatory drugs increase endothelial tissue factor expression in vitro;Thrombosis Research;2011-03

3. Safety, Tolerability and Biological Effects of Long-Term Metronomic Administration of Non-Cytotoxic Anti-Angiogenic Agents;Oncology;2009

4. Tumour Necrosis Factor – Misnomer and Therapeutic Target;Renal Cell Carcinoma;2009

5. The Combination of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma—Is Not the Answer;American Journal of Clinical Oncology;2008-10